Modification of the terminal residue of apelin-13 antagonizes its hypotensive action.
Endocrinology. 2005 Jan;146(1):231-6. doi: 10.1210/en.2004-0359. Epub 2004 Oct 14.
Endocrinology. 2005.
PMID: 15486224